Clarivate

MARCH 8, 2023

In recent years, there has been an increased focus on real world evidence to advance medical science and improve patient quality of life. The Professional Society for Health Economics and Outcomes Research (ISPOR) has cited real world evidence (RWE) as the number one trend in healthcare decision making for the second year running [1].

Patients 59

Patients Biopharma Medical science Electronics 59

European Pharmaceutical Review

FEBRUARY 22, 2023

Of the 175 new drugs approved by the US Food and Drug Administration (FDA) between 2016 and 2019, most were biologics. This trial is anticipated to begin in the second half of 2023. Biologics Global Market Report 2023. 2023 [cited 2023Feb]. References Urquhart L. Top companies and drugs by sales in 2021. 2022;21(4):251–.

Food and Drug Administration 88

Food and Drug Administration Manufacturing Safety Pharmaceutical 88

Medgadget

FEBRUARY 17, 2023

Interestingly, due to FDA’s regulatory methodology, surgical robots have to be approved for specific indications by the agency. This year it is scheduled for May 16-18, 2023 in Tel Aviv, and topics range from medical robotics, to bio-convergence, to the impact of AI on biopharma.

Physicians 80

Physicians Engineering Side effects Leads 80

Medgadget

MARCH 2, 2023

The FDA looked at the data, saw it promising, and asked for a small feasibility study in the U.S. This will hopefully lead to an FDA approval for its first indication, after which Alpha TAU plans on expanding to other types of cancer and geographic regions such as Europe and Japan. The rest of the patients had partial responses.

Manufacturing 83

Manufacturing Leads Patients Medicine 83